CLOSTRIDIOIDES DIFFICILE INFECTION
Clinical trials for CLOSTRIDIOIDES DIFFICILE INFECTION explained in plain language.
Never miss a new study
Get alerted when new CLOSTRIDIOIDES DIFFICILE INFECTION trials appear
Sign up with your email to follow new studies for CLOSTRIDIOIDES DIFFICILE INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a sweetener beat a gut infection? new trial explores xylitol for c. diff in IBD
Disease control Not yet recruitingThis study tests if xylitol, a common sweetener, can safely clear C. difficile bacteria from the gut in people with inflammatory bowel disease (IBD). About 99 adults with mild or inactive IBD will take either a low or high dose of xylitol or a placebo for four weeks. Researchers …
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a sweetener beat a gut infection? early trial tests xylitol for c. diff in IBD patients
Disease control Not yet recruitingThis pilot study tests whether xylitol, a common sugar alcohol, can safely clear C. difficile bacteria from the guts of people with inflammatory bowel disease (IBD). About 69 adults with mild or inactive IBD will take different doses of xylitol for up to 8 weeks. Researchers will…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: EARLY_PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New hope for IBD patients: can a better antibiotic stop c. diff for good?
Disease control Not yet recruitingThis study compares two antibiotics, fidaxomicin and vancomycin, to see which one is better at clearing C. difficile bacteria from the gut in people with inflammatory bowel disease (IBD). About 60 adults with IBD will take one of the two antibiotics for 10 days and be followed fo…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Bile acid breakthrough: could a Decades-Old pill stop c. diff in its tracks?
Prevention Not yet recruitingThis early-phase trial tests whether adding Ursodeoxycholic Acid (UDCA) to standard antibiotics can prevent Clostridioides difficile (C. diff) infection from returning. About 30 adults with C. diff and risk factors for recurrence will take UDCA three times daily for up to eight w…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: EARLY_PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
FMT vs antibiotics: which works better Long-Term for c. diff?
Knowledge-focused Not yet recruitingThis study looks at adults who had a C. diff infection and were treated with either a fecal transplant (FMT) or antibiotics alone. Researchers want to see if FMT leads to healthier gut bacteria and fewer health problems years later. Participants will give blood, stool, and urine …
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Sponsor: Umeå University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC